MX2018004322A - Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano. - Google Patents

Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano.

Info

Publication number
MX2018004322A
MX2018004322A MX2018004322A MX2018004322A MX2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A MX 2018004322 A MX2018004322 A MX 2018004322A
Authority
MX
Mexico
Prior art keywords
man
neutralizing antibodies
antibodies against
serum
insulin
Prior art date
Application number
MX2018004322A
Other languages
English (en)
Inventor
Kulshrestha Abhishek
Shankar Maurya Ravi
Sabde Sudeep
Hajela Pallavi
Kalani Pawan
Melarkode Ramakrishnan
Chirmule Narendra
Original Assignee
Biocon Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocon Ltd filed Critical Biocon Ltd
Publication of MX2018004322A publication Critical patent/MX2018004322A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/62—Insulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención proporciona un método in vitro para detectar la presencia de anticuerpos neutralizantes contra insulina humana recombinante (rHI) en suero humano. También proporciona un kit para un método in vitro para la detección de la presencia de anticuerpos neutralizantes para insulina humana recombinante (rHI).
MX2018004322A 2015-10-15 2016-10-15 Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano. MX2018004322A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN5528CH2015 2015-10-15
PCT/IB2016/056191 WO2017064678A1 (en) 2015-10-15 2016-10-15 Method for detecting neutralizing antibodies against recombinant human insulin in human serum

Publications (1)

Publication Number Publication Date
MX2018004322A true MX2018004322A (es) 2018-11-09

Family

ID=58518001

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018004322A MX2018004322A (es) 2015-10-15 2016-10-15 Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano.

Country Status (10)

Country Link
US (1) US11340238B2 (es)
EP (1) EP3362793B1 (es)
JP (1) JP6835835B2 (es)
AU (1) AU2016337598B2 (es)
BR (1) BR112018007551A2 (es)
CA (1) CA3000929C (es)
MX (1) MX2018004322A (es)
MY (1) MY192159A (es)
RU (1) RU2725142C2 (es)
WO (1) WO2017064678A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210284716A1 (en) 2020-03-11 2021-09-16 Immunitybio, Inc. ACE2-Fc Trap
US11857620B2 (en) 2020-03-11 2024-01-02 Immunitybio, Inc. Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus
CN112362649A (zh) * 2020-11-09 2021-02-12 长春金赛药业有限责任公司 一种rhGH中和抗体的检测方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225583A (en) * 1987-08-06 1991-07-26 Merck & Co Inc Process for purifying hepatitis a virions (hav)
AU1812595A (en) * 1994-02-28 1995-09-11 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Cell lines for the identification of substances affecting insulin receptor mediated signal transduction
US7087726B2 (en) * 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
JP4197180B2 (ja) * 2005-06-29 2008-12-17 株式会社シバヤギ 検体中の内分泌物質測定方法
CA2694034A1 (en) * 2007-07-27 2009-02-05 Pfizer Limited Antibody purification process by precipitation
CA2885721A1 (en) * 2012-07-11 2014-01-16 Biomimetic Therapeutics, Llc Cell-based assay for neutralizing antibodies
RS58212B1 (sr) * 2014-02-11 2019-03-29 Genzyme Corp Testovi za otkrivanje prisustva ili količine anti-lek antitela

Also Published As

Publication number Publication date
EP3362793A4 (en) 2018-08-22
WO2017064678A1 (en) 2017-04-20
BR112018007551A2 (pt) 2018-10-23
RU2725142C2 (ru) 2020-06-30
EP3362793A1 (en) 2018-08-22
EP3362793B1 (en) 2019-08-28
JP2018532115A (ja) 2018-11-01
RU2018114524A3 (es) 2020-02-26
US11340238B2 (en) 2022-05-24
MY192159A (en) 2022-08-03
CA3000929A1 (en) 2017-04-20
AU2016337598B2 (en) 2022-10-13
JP6835835B2 (ja) 2021-02-24
AU2016337598A1 (en) 2018-04-26
US20180306814A1 (en) 2018-10-25
RU2018114524A (ru) 2019-11-15
CA3000929C (en) 2023-09-19

Similar Documents

Publication Publication Date Title
PH12017500861A1 (en) Anti-interleukin-33 antibodies and uses thereof
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
EP3482209C0 (en) ALPHA SYNUKLEIN DETECTION TEST AND METHOD FOR DIAGNOSING ALPHA SYNUKLEINOPATHIES
MA40390A (fr) Procédés d'analyse impliquant des nanoparticules dissociables
MX2016011641A (es) Procedimiento de preparacion de proteinas plasmaticas humanas.
WO2015114506A3 (en) Biosensors for the detection of infection and associated maladies
EP3654036A3 (en) Stomach cancer biomarker and detection method
EP3665187A4 (en) TEST PROCEDURES FOR IMPROVED ANALYTE DETECTION
IN2014DN05885A (es)
IL254687A0 (en) A bio-sensor system for rapid identification of an analyte
IL250646A0 (en) A process for conjugating a peptide or protein with a reagent containing a leaving group that includes a peg moiety
MX2018012550A (es) Composiciones y metodos para la deteccion de proteinas de celulas huesped.
MX2017005888A (es) Dispositivos, sistemas y metodos para la deteccion de analitos.
EP3096784A4 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
MX2018004322A (es) Metodo para detectar anticuerpos neutralizantes contra la insulina mana recombinante en suero mano.
MX2019002818A (es) Metodos para detectar anticuerpos neutralizantes anti-leptina.
EP3488241A4 (en) PANEL DETECTION OF PROTEIN BIOMARKERS ASSOCIATED WITH HDL
WO2015077342A3 (en) Detection of arginine methylation of egfr for prediction of resistance to therapy
MX2017005310A (es) Metodos basados en proximidad para seleccion de parejas para ligadura.
EP3925979A3 (en) Fgfr-tacc fusion proteins and methods thereof
MX2016011368A (es) Un eje de entrada entre un aparato y un aparato separado.
EP3521450A4 (en) METHOD FOR DETECTING SMALL RNA OR PROTEINS RELATED TO SMALL RNA
EP3593122A4 (en) METHOD OF DETECTION OF ANALYTES
EP3106466A4 (en) Peptide, magnetic peptide and method for detecting celiac disease